Any industry that depends a lot on innovation is prone to be disrupted and it is often seen that those disruptive companies go on to create significant wealth for their investors. However, at the same time, it is necessary for investors to do their research diligently and then come up with stocks that may be worth following. This article is going to give you a glimpse into four companies that are currently disrupting the massive healthcare industry. You could do well to add some or all of those to your watch lists.

Therma Bright Inc (OTCMKTS:TBRIF) (THRM.V) – Therma Bright Inc is best known for having developed the AcuVid™ COVID-19 Rapid Antigen Saliva Test and other similar innovative devices. The company has not been in the news for quite a while but back on August 4, it made a key announcement.

It announced that it had continued its discussions with the United States Food and Drug Administration with regards to the Emergency Use Authorization for its AcuVid™ COVID-19 Rapid Antigen Saliva Test. It is something that investors could keep an eye on.

Halberd Corporation (OTCMKTS: HALB) – The next one that could be added to this list is that of Halberd Corporation. The company has done exemplary research work in recent times and recently got a letter of endorsement from the President of the NFL Retired Players Association, Carl Eller.

The letter noted spoke about the research work done by Halberd with regards to the development of treatments for Traumatic Brain Injury. Such injuries may often lead to severe neurodegenerative diseases like Epilepsy, Parkinson’s, and Alzheimer’s among others.

Pressure BioSciences Inc (OTCMKTS: PBIO) – Pressure BioSciences Inc is best known for making pressure-based instruments that can be deployed in several industries, including healthcare-related ones.

Yesterday the company was in focus after it announced that it had executed a sales, manufacturing, and distribution agreement with the company Canopy CBD Farms LLC. The company is based out of Massachusetts and manufactures hemp-based CBD products.

IPA/Immunoprecise Antibodies Ltd. – (NASDAQ: IPA) (TSXV: IPA) – The stock has been witnessing a consistent uptrend over the past month with a gain of over 55%. Impressively, the stock is now trading well above its 50-Day and 200-Day moving averages of $4.30 and $5.10 respectively.

In the FY 2022, the Company achieved record revenues of $19.4 million, up 8.1% from $17.9 million in the fiscal year 2021 The Company achieved record revenues of $5.2 million for the three months ended April 30, 2022, an increase of 7.4% over the same period last year. The Company achieved an increase in CRO revenue (total revenue minus Talem asset out-licensing revenue) of 15.9% over the same period last year.

Human Unitec International Inc (OTCMKTS: HMNU) stock is seeing continuous support at the lower levels on cheap valuation. The company announced that on July 25 it was going to launch the BCEP or BlockChain Property Enterprises. It is a highly ambitious project that is going to be involved the tokenization of real estate opportunities from all across the globe.

RushNet Inc (OTCMKTS:RSHN) – could be added to the watch lists by investors today. It could be an interesting proposition since last week the company announced that it was going to roll out its Human Monkeypox Virus testing service through its subsidiary heliosDX across the United States. The service is being provided by heliosDX in collaboration with a lab partner.

BioLife Sciences Inc (OTCMKTS: BLFE) – The last one to make it to the list is BioLife Sciences, which was in the news day before yesterday after it announced that it had launched the first of its CBD consumer products. The company noted that it was going to offer as many as six different industrial hemp-based tincture products to the consumer. It was a major new move from the company and one that you could follow closely.

By admin